(Q55094759)

19 June 2018

title

Association of transarterial chemoembolization with survival in patients with unresectable hepatocellular carcinoma. (English)

1 reference

19 June 2018

author name string

Peng Wang

1

1 reference

19 June 2018

Lili Sheng

2

1 reference

19 June 2018

Guoxiang Wang

3

1 reference

19 June 2018

Heping Wang

4

1 reference

19 June 2018

Xinyu Huang

5

1 reference

19 June 2018

Xiaoxing Yan

6

1 reference

19 June 2018

Xiaohua Yang

7

1 reference

19 June 2018

Renguang Pei

8

1 reference

19 June 2018

publication date

7 January 2014

1 reference

19 June 2018

Molecular and Clinical Oncology

published in

1 reference

19 June 2018

volume

2

1 reference

19 June 2018

issue

2

1 reference

19 June 2018

page(s)

203-206

1 reference

19 June 2018

Management of hepatocellular carcinoma: An update

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917780

Hepatocellular carcinoma: A global view.

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917780

Systemic treatment of hepatocellular carcinoma: dawn of a new era?

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917780

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917780

Transarterial chemoembolization for hepatocellular carcinoma

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917780

Management of hepatocellular carcinoma

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917780

Chemoembolization for hepatocellular carcinoma

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917780

Racial discrepancies in the outcome of patients with hepatocellular carcinoma

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917780

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917780

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917780

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917780

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917780

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917780

Randomized control trials on chemoembolization for hepatocellular carcinoma: is there room for new studies?

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917780

Ethnic differences in the behavior of hepatocellular carcinoma

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917780

Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis?

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917780

Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917780

Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma.

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917780

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3917780

Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival

22 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24649333

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24649333

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Systemic treatment of hepatocellular carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24649333

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3892/MCO.2014.239

1 reference

19 June 2018

PMC publication ID

3917780

1 reference

19 June 2018

PubMed publication ID

24649333

1 reference

19 June 2018